English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
 
 
DownloadE-Mail
  New use of psychotropic medication after hospitalization among people with dementia

Moellers, T., Perna, L., Stocker, H., Ihle, P., Schubert, I., Schoettker, B., et al. (2020). New use of psychotropic medication after hospitalization among people with dementia. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 35(6), 640-649. doi:10.1002/gps.5282.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Moellers, Tobias, Author
Perna, Laura1, Author           
Stocker, Hannah, Author
Ihle, Peter, Author
Schubert, Ingrid, Author
Schoettker, Ben, Author
Froelich, Lutz, Author
Brenner, Hermann, Author
Affiliations:
1Dept. Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Max Planck Society, ou_2035295              

Content

show
hide
Free keywords: NURSING-HOME RESIDENTS; ALZHEIMERS-DISEASE; NEUROPSYCHIATRIC SYMPTOMS; PSYCHOLOGICAL SYMPTOMS; DRUG-USE; MANAGEMENT; IMPACT; POLYPHARMACY; ASSOCIATION; PREVALENCEGeriatrics & Gerontology; Psychiatry; claims data; dementia; hospitalization; psychotropic medication;
 Abstract: Objectives Psychotropic medication is commonly used among people with dementia (PWD), but it shows modest efficacy and it has been associated with severe adverse events. Hospitalizations are an opportunity for medication management as well as treatment recommendations for outpatient physicians. The aim of this study was to asses factors associated with new use of psychotropic medication after hospitalization among PWD.
Methods We conducted a retrospective dynamic cohort study from 2004 to 2015 using claims data from a German health insurance company. PWD were identified by an algorithm that included ICD-10 diagnosis and diagnostic measures. The medication classes included were antidepressants, antipsychotics, anxiolytics or hypnotics/sedatives, and Alzheimer's medication. The assessment period was up to 30 days after discharge from the hospital across four hospitalizations.
Results The main predictors for new use of psychotropic medication were similar across medication classes. Neuropsychiatric symptoms (NPS) and the need of care were associated with higher odds of new use of antidepressants, antipsychotics, and anxiolytics or hypnotics/sedatives. A hospital stay due to dementia was an independent predictor for new use across medication classes as well. Delirium increased the odds for new use of antipsychotics and anxiolytics or hypnotics/sedatives.
Conclusions Factors associated with new use of psychotropic medication included delirium, NPS, and the need of care in PWD. The findings highlight the need for preventive interventions and non-medical treatment options in regards to delirium and NPS as well as for a more intensive use of screening tools for inappropriate medication use among PWD.
Key points
The percentage of new users was 1.8%, 7.1%, 2.1%, and 2.5% across hospitalizations for antidepressants, antipsychotics, anxiolytics or hypnotics/sedatives, and Alzheimer's medication, respectively.
83.0%, 61.9%, 56.9%, and 88.1% of new users received antidepressants, antipsychotics, anxiolytics or hypnotics/sedatives, and Alzheimer's medication for more than 6 weeks.
Delirium and neuropsychiatric symptoms were associated with significantly increased odds of new psychotropic medication use.
Hospital stays due to dementia and the need of care were predictors for new use of psychotropic medication.

Details

show
hide
Language(s): eng - English
 Dates: 2020
 Publication Status: Issued
 Pages: 10
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Identifiers: ISI: 000532572300007
DOI: 10.1002/gps.5282
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: 111 RIVER ST, HOBOKEN 07030-5774, NJ USA : WILEY
Pages: - Volume / Issue: 35 (6) Sequence Number: - Start / End Page: 640 - 649 Identifier: ISSN: 0885-6230